- +91-361-2221716
- +91-70990-23636
- info@chemex.global



Trusted API Pharma Company in Assam For Quality Solutions
Founded in 2021, Chemex Global is a manufacturer of APIs and Pharmaceutical Intermediates, located in Guwahati, Assam. We are a subsidiary of Jain Group Ventures, a company with over 30 years of experience in the Pharmaceutical Supply Chain Industry. We are committed to research-based indigenous solutions and have established one of the largest integrated R&D labs in Eastern India. We are proud to be the first API Manufacturing Unit in the Northeastern region of India and one of the biggest capacity units in the entire Eastern India.

APIs
APIs, or Active Pharmaceutical Ingredients, serve as the backbone of the pharmaceutical industry, and we pride ourselves on sourcing and providing top-notch APIs, ensuring the efficacy and safety of the medications we offer.
Our Products

Intermediates
Intermediates play a crucial role in the pharmaceutical industry, forming the essential building blocks in the production of drugs and medications. We specialise in providing a diverse range of comprehensive catalogue of these essential components,
Our Products
APIs
APIs, or Active Pharmaceutical Ingredients, serve as the backbone of the pharmaceutical industry, and we pride ourselves on sourcing and providing top-notch APIs, ensuring the efficacy and safety of the medications we offer.
Intermediates
Intermediates play a crucial role in the pharmaceutical industry, forming the essential building blocks in the production of drugs and medications We specialise in providing a diverse range of comprehensive catalogue of these essential components,
Customs Synthesis
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Polymorph Screening
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Why Choose Us?

Quality Assurance
Our stringent quality standards ensure the production of high-grade APIs and Pharma Intermediates, meeting global regulatory requirements with precision.

Research and Development Focus
We invest extensively in research and development, fostering a culture of innovation to introduce groundbreaking APIs and Pharma Intermediates.

Environmental Responsibility
Employing cutting-edge technology and innovative processes, we manufacture APIs and Pharma Intermediates that adhere to the latest industry advancements.

State-of-the-art & GMP accredited
Our dedication to GMP regulations guarantees the production of high-quality APIs and Pharma Intermediates, meeting stringent global standards for quality control and environmental integrity.

Quality Assurance
Our stringent quality standards ensure the production of high-grade APIs and Pharma Intermediates, meeting global regulatory requirements with precision.

Research and Development Focus
We invest extensively in research and development, fostering a culture of innovation to introduce groundbreaking APIs and Pharma Intermediates.

Environmental Responsibility
Employing cutting-edge technology and innovative processes, we manufacture APIs and Pharma Intermediates that adhere to the latest industry advancements.

State-of-the-art & GMP accredited
Our dedication to GMP regulations guarantees the production of high-quality APIs and Pharma Intermediates, meeting stringent global standards for quality control and environmental integrity.

Quality, continuity and flexibility
At Chemex Global, skilled professionals examine chemical and pharmaceutical intermediates as well as APIs, utilising advanced analytical equipment at the utmost technical proficiency. Streamlined processes empower the quality control team to adapt swiftly to inquiries, ensuring the delivery of exceptional quality, even for orders with tight deadlines.

GMP Manufacturing Facility
Our company adheres to Good Manufacturing Practice (GMP) regulations and has established an integrated system for quality control and environmental protection. Our GMP manufacturing facility is equipped with state-of-the-art technology that sets the industry benchmark, with the promise of delivering nothing less than excellence.

Responsibility
Responsibility is woven into the fabric of our brand, guiding our commitment to sustainable practices and ethical manufacturing. At every step of the API and Intermediate production process, we prioritise environmental stewardship, employee well-being, and community impact.

R&D
Led by experienced researchers and armed with cutting-edge technology, our R&D team pioneers solutions, driving advancements in pharmaceuticals and chemical synthesis. From concept to realisation, we are committed to shaping the future, delivering groundbreaking products that uphold our legacy of excellence in the industry.

Quality
Assurance
Assurance
Our stringent quality standards ensure the production of high-grade APIs and Pharma Intermediates, meeting global regulatory requirements with precision.

Research and Development
Focus
Focus
We invest extensively in research and development, fostering a culture of innovation to introduce groundbreaking APIs and Pharma Intermediates.

Environmental
Responsibility
Responsibility
Employing cutting-edge technology and innovative processes, we manufacture APIs and Pharma Intermediates that adhere to the latest industry advancements.

State-of-the-art & GMP accredited
Our dedication to GMP regulations guarantees the production of high-quality APIs and Pharma Intermediates, meeting stringent global standards for quality control and environmental integrity.

View the Latest News

Plant Inauguration
On the 22nd of February, Chemex Global proudly inaugurated its cutting-edge pharma-API plant facility, marking a pivotal moment in our commitment to innovation, quality, and growth. This event served as a testament to our unwavering dedication to advancing the field of API and pharmaceutical intermediate production.

Introducing Our Recently Developed API- Sacubitril-Valsartan
As a newly developed API, Sacubitril Valsartan embodies our commitment to pushing the boundaries of pharmaceutical innovation. Manufactured to address the unmet needs of patients suffering from chronic heart failure